Impact of Risk-Based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the childhood cancer survivor study.
Friedman DN, Goodman PJ, Leisenring WM, Diller LR, Cohn SL, Howell RM, Smith SA, Tonorezos ES, Wolden SL, Neglia JP, Ness KK, Gibson TM, Nathan PC, Turcotte LM, Weil BR, Robison LL, Oeffinger KC, Armstrong GT, Sklar CA, Henderson TO.
Friedman DN, et al. Among authors: gibson tm.
J Natl Cancer Inst. 2024 Mar 9:djae062. doi: 10.1093/jnci/djae062. Online ahead of print.
J Natl Cancer Inst. 2024.
PMID: 38460547